Amyndas Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $12.6K

  • Investors
  • 4

Amyndas Pharmaceuticals General Information

Description

Developer of a complementary therapeutic designed to provide the transformative therapies for dealing with inflammatory diseases. The company offers drugs for the treatment of inflammatory diseases and age-related macular degeneration, as well as for the treatment of chronic inflammation in dialysis and ischemia-reperfusion, enabling patients to combat inflammatory and kidney diseases.

Contact Information

Website
www.amyndas.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • PO Box 1045, 125 South King Street
  • Suite 2A
  • Jackson, WY 83001-1045
  • United States
+1 (307)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • PO Box 1045, 125 South King Street
  • Suite 2A
  • Jackson, WY 83001-1045
  • United States
+1 (307)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amyndas Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 15-Nov-2014 $12.6K Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant Completed Generating Revenue
1. University Spin-Out 01-Jan-2013 Completed Startup
To view Amyndas Pharmaceuticals’s complete valuation and funding history, request access »

Amyndas Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Association of Pharmaceutical Enterprises of Greece Corporation
University of Pennsylvania University
European Commission Government
Penn Center for Innovation Accelerator/Incubator
To view Amyndas Pharmaceuticals’s complete investors history, request access »

Amyndas Pharmaceuticals FAQs

  • When was Amyndas Pharmaceuticals founded?

    Amyndas Pharmaceuticals was founded in 2013.

  • Where is Amyndas Pharmaceuticals headquartered?

    Amyndas Pharmaceuticals is headquartered in Jackson, WY.

  • What industry is Amyndas Pharmaceuticals in?

    Amyndas Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Amyndas Pharmaceuticals a private or public company?

    Amyndas Pharmaceuticals is a Private company.

  • What is Amyndas Pharmaceuticals’s current revenue?

    The current revenue for Amyndas Pharmaceuticals is .

  • Who are Amyndas Pharmaceuticals’s investors?

    The Association of Pharmaceutical Enterprises of Greece, University of Pennsylvania, European Commission, and Penn Center for Innovation have invested in Amyndas Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process